| Pharmaceutical Information |
| Drug Name |
Foscarnet |
| Drug ID |
BADD_D02421 |
| Description |
An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpes viruses and HIV. |
| Indications and Usage |
For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) and for treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients. |
| Marketing Status |
Not Available |
| ATC Code |
J05AD01 |
| DrugBank ID |
DB00529
|
| KEGG ID |
D00579
|
| MeSH ID |
D017245
|
| PubChem ID |
3415
|
| TTD Drug ID |
D0OT0O
|
| NDC Product Code |
Not Available |
| Synonyms |
Foscarnet | Phosphonoformic Acid | Foscarnet Trisodium Salt | Foscarnet Calcium (2:3) Salt | Foscarnet Disodium Salt | Foscarnet Magnesium (2:3) Salt | Trisodium Phosphonoformate | Phosphonoformate | Foscarnet Sodium | Foscarnet Trilithium Salt | Foscarnet Tripotassium Salt | Foscarnet Sodium Hexahydrate | Foscavir | Foscarnet Barium (2:3) Salt | Foscarnet Manganese (2+) (2:3) Salt |
|
| Chemical Information |
| Molecular Formula |
CH3O5P |
| CAS Registry Number |
4428-95-9 |
| SMILES |
C(=O)(O)P(=O)(O)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
